HAIC
3 clinical trials
4 abstracts
4 indications
Indication
Hepatocellular CarcinomaIndication
Colorectal CancerIndication
Colorectal AdenocarcinomaIndication
Colorectal Cancer MetastaticAbstract
A phase II study to evaluate the efficacy and safety of fruquintinib combined with tislelizumab and hepatic artery infusion chemotherapy (HAIC) for advanced colorectal cancer liver metastases: An updated analysis of survival.Org: Liver Surgery Department, Department of Traditional Chinese Medicine/ Integrative Oncology,
Abstract
Comparing the efficacy and safety of HepaSphere drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy versus hepatic arterial infusion chemotherapy alone in unresectable colorectal liver metastases.Org: Department of Interventional Therapy,
Clinical trial
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitor in Treating Potentially Resectable Locally Advanced Hepatocellular Carcinoma: A Prospective, Phase II Clinical StudyStatus: Active (not recruiting), Estimated PCD: 2020-07-20
Clinical trial
A Study to Evaluate the Efficacy and Safety of the Hepatic Arterial Infusion Chemotherapy(HAIC) Combined With Sintilimab and Bevacizumab Biosimilar in Unresectable Hepatocellular Carcinoma.Status: Recruiting, Estimated PCD: 2022-01-10
Clinical trial
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)Status: Recruiting, Estimated PCD: 2025-10-31
Abstract
Efficacy and safety of tislelizumab combined with lenvatinib and FOLFOX4-HAIC in conversion therapy of middle-advanced stage hepatocellular carcinoma (HCC): A real-world retrospective study.Org: The Second Affiliated Hospital of Air Force Medical University, Xi'an Medical College,
Abstract
Donafenib, anti-PD-1 antibodies, plus hepatic arterial infusion chemotherapy (HAIC) as conversion therapy in patients with initially unresectable hepatocellular carcinoma (HCC): A prospective, single-arm, phase 2 study.Org: The Fifth Medical Center of the PLA General Hospital, The Fifth Medical Center of Chinese PLA General Hospital,